Myriam Curet bought $804 of INSP
director at Inspire Medical Systems, Inc.. 5 shares at an average of $160.72, traded Mar 20, 2025, filed Nov 24, 2025.
Score components
- +15RoleDirector
- 0Trade size$804 at market
- -5Relative to holdingsUnder 1% of holdings (0.1%)
- +14Price context2% above the 52-week low; 25% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -18.4%, 3m -50.3%, 6m -62.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-25-115560, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 20, 2025 | POpen-market purchase Common Stock | +4 | $163.84 | $655 | 3,370 | Nov 24, 2025 |
| Apr 7, 2025 | POpen-market purchase Common Stock | +1 | $148.26 | $148 | 3,371 | Nov 24, 2025 |
| May 8, 2025 | SOpen-market sale Common Stock | -2 | $153.22 | $306 | 3,369 | Nov 24, 2025 |
| Aug 8, 2025 | SOpen-market sale Common Stock | -4 | $77.28 | $309 | 3,365 | Nov 24, 2025 |
Related signals
Other insiders at Inspire Medical Systems, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 22Weak | INSPsell Inspire Medical Systems, Inc. | Jason P Kelly See Remarks | $57k 963 shares | -5% | |
| 33Weak | Inspire Medical Systems, Inc. | John Rondoni See Remarks | $114k 2,641 shares | -9% | |
| 28Weak | Inspire Medical Systems, Inc. | John Rondoni See Remarks | $30k 700 shares | -2% | |
| 8Weak | Inspire Medical Systems, Inc. | Shawn McCormick director | $32k 696 shares | -2% | |
| 0Weak | Inspire Medical Systems, Inc. | John Rondoni See Remarks | $11k 109 shares | -1% | |
| 6Weak | Inspire Medical Systems, Inc. | Shawn McCormick director | $167k 1,200 shares | -5% | |
| 8Weak | Inspire Medical Systems, Inc. | Shawn McCormick director | $255k 2,000 shares | -7% | |
| 30Weak | Inspire Medical Systems, Inc. | Myriam Curet director | $616 6 shares | -0% | |
| 52Moderate | INSPsell Inspire Medical Systems, Inc. | Richard Buchholz Chief Financial Officer | $1.0M 11,000 shares | -20% | |
| 41Moderate | Inspire Medical Systems, Inc. | John Rondoni See Remarks | $259k 1,734 shares | -11% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.